ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
nulojix
bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - Ónæmisbælandi lyf - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
refludan
celgene europe ltd. - lepirúdín - thromboembolism; thrombocytopenia - blóðþurrðandi lyf - segavarnarlyf hjá fullorðnum sjúklingum með tegund ii blóðflagnafæð af völdum lifrarbólgu og segarek í bláæðum. greining ætti að vera staðfest af heparín völdum blóðflögum örvun prófi eða sams próf.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
asacol magasýruþolin tafla 400 mg
tillotts pharma ab - mesalazinum inn - magasýruþolin tafla - 400 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
asacol magasýruþolin tafla 800 mg
tillotts pharma ab - mesalazinum inn - magasýruþolin tafla - 800 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
ketador vet. (ketamidor) stungulyf, lausn 100 mg/ml
vetviva richter gmbh - ketaminum hýdróklóríð - stungulyf, lausn - 100 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
procamidor vet. stungulyf, lausn 20 mg/ml
vetviva richter gmbh - procainum hýdróklóríð - stungulyf, lausn - 20 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
nicorette microtab classic (nicorette (tungurótartöflur)) tungurótartafla 2 mg
mcneil denmark aps - nicotinum cyclodextrin-komplex - tungurótartafla - 2 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
clariscan stungulyf, lausn 0,5 mmól/ml
ge healthcare as - acidum gadotericum inn - stungulyf, lausn - 0,5 mmól/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
clariscan stungulyf, lausn í áfylltri sprautu 0,5 mmól/ml
ge healthcare as - acidum gadotericum inn - stungulyf, lausn í áfylltri sprautu - 0,5 mmól/ml
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
imlygic
amgen europe b.v. - talimogene laherparepvec - melanoma - Æxlishemjandi lyf - imlygic er ætlað fyrir meðferð fullorðnir með unresectable húðkrabbanum það er svæðisbundið eða fjarskyldir sjúklingum (stigi iiib, iiic og ivm1a) með engin bein, heilans, lungum eða öðrum innyflum sjúkdómur.